Research and Development

The global proteomics market is predicted to grow to exceed $24.8 billion by 2024, according to a new report by …

Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …

As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …

UK microbiology and chemical analysis company ALS Pharmaceutical has quadrupled the size of its facility in Ely, Cambridgeshire as part …

Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …

Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …

London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …

Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …

Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …

According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

The US Food and Drug Administration has accepted the supplemental biologics license application from MSD, known as Merck in the …